Cindy Motz
Stock Analyst at Goldman Sachs
(n/a)
# 4,433
Out of 4,834 analysts
14
Total ratings
8.33%
Success rate
-30%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $97.65 | -21.15% | 3 | Oct 21, 2022 | |
| HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $4.12 | +337.42% | 5 | Aug 10, 2022 | |
| DOCS Doximity | Maintains: Buy | $53 → $46 | $58.45 | -21.30% | 3 | Aug 8, 2022 | |
| TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $7.25 | +396.55% | 3 | Jul 28, 2022 |
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $97.65
Upside: -21.15%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $4.12
Upside: +337.42%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $58.45
Upside: -21.30%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $7.25
Upside: +396.55%